RGRX OTC
RegeneRx Biopharmaceuticals, Inc.
1W: +0.0%
1M: +57.1%
3M: +83.3%
YTD: +266.7%
1Y: +450.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$941K
+5.0% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$941K
+5.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$941K
-217.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$2M | -$1M | -$2M | -$2M | -$2M |
| Depreciation & Amort. | $3K | $1K | $0 | $0 | $0 |
| Stock-Based Comp. | $276K | $270K | $332K | $398K | $512K |
| Change in Working Capital | $178K | -$110K | $22K | $30K | $39K |
| Other Non-Cash Items | $649K | $105K | $162K | $179K | $236K |
| Operating Cash Flow | -$888K | -$1M | -$1M | -$990K | -$941K |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $1M | $555K | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $944K | $241K | -$2K | $35K | $0 |
| Financing Cash Flow | $944K | $2M | $795K | $2M | $0 |
| Net Change in Cash | $56K | $403K | -$212K | $804K | -$941K |
| Cash End of Period | $237K | $640K | $428K | $1M | $291K |
| Free Cash Flow | -$888K | -$1M | -$1M | -$990K | -$941K |